Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010) - Wikidata - thesis-toulmin - TriplyDB

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

http://www.wikidata.org/entity/Q34100598

about

Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy Multicenter outbreak of infections by Saprochaete clavata, an unrecognized opportunistic fungal pathogen Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference Unexpected Transcripts in Tn7 orf19.2646 C. albicans Mutant Lead to Low Fungal Burden Phenotype In vivo Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Antimicrobial and Antibiofilm Activity of Chitosan on the Oral Pathogen Candida albicans.Management of invasive candidiasis in nonneutropenic ICU patients.Clinical and therapeutic aspects of candidemia: a five year single centre study.Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program Performance assessment of two lysis methods for direct identification of yeasts from clinical blood cultures using MALDI-TOF mass spectrometry.Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.Secular Trends in Utilization of Critical Care Services Among Candidemia-Associated Hospitalizations: A Population-Based Cohort Study.Dose escalation studies with caspofungin against Candida glabrata.Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.Phosphatidylethanolamine Metabolism in Health and Disease.Temporal Trends of the Clinical, Resource Use and Outcome Attributes of ICU-Managed Candidemia Hospitalizations: A Population-Level Analysis.Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts.(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.The risk and clinical outcome of candidemia depending on underlying malignancy.Candida glabrata--unique features and challenges in the clinical management of invasive infections.ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species.Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Plant extracts: initial screening, identification of bioactive compounds and effect against Candida albicans biofilms.Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.Azole Resistance in Candida glabrata.The current treatment landscape: candidiasis.Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.Rapid Detection and Identification of Candidemia by Direct Blood Culturing on Solid Medium by Use of Lysis-Centrifugation Method Combined with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).

P2860

Q26745677-932DB333-AAD4-4C0A-A4FE-CE57048E18B5 Q28254032-104CC3FC-24C3-4CF2-B29A-DA04EEA3906B Q29994504-F4022850-10B9-49C6-975C-FDD358C9CE2D Q33640559-603A233A-C907-4E55-BF1F-1AA86C023259 Q33690201-CD8230BB-62FF-4BB4-B358-566C8E6284A9 Q33712955-607AB45E-F9E5-47A6-9B12-14E9171A0FE0 Q34809708-3D8911EA-7ACD-475A-A61C-07BB42D5FF0A Q35122093-0317EDF9-B8C1-4980-A077-13A44C1BD36A Q35641217-1396804C-773A-43D4-8BD7-349A3CD6E78B Q35775400-B87BBAB9-E26B-4F4A-9FBF-EAD44D15D200 Q35816268-B7DF49BE-C235-46F0-AA57-ED31682D817B Q35903892-3AF4732E-4020-4850-90DB-02022989E828 Q36047197-2716EE74-E2EF-4109-AFF5-F600126B2770 Q36176809-B936F8F6-4117-4E3C-B25E-828EA91C4F4B Q36364768-16918528-AE9A-4071-9CCC-967C6B90DF3B Q36376559-27556BB1-88EE-46AB-AFC8-0B7672BFD4A2 Q36441468-D182AFB7-F6D1-416C-85E0-5FAD91450CF7 Q36652965-7F24741C-7E64-4AAB-AE68-9BFA64659A5B Q36658546-A0E295DE-9A2E-4739-A178-FEC3BBF3860E Q36797990-FA73755B-0EE3-4209-B0CC-166E9ED6C45E Q36902916-002F855B-4726-43CF-AC71-4CF70B6EB286 Q36953947-4BB3563F-9B12-4FC9-86CC-C44F39E3BC04 Q37225323-96D1E81F-08D9-4212-B68F-BD93B3AC9EF3 Q37528498-3986C336-9C6A-4557-B63B-FEB36B3E79A1 Q37580801-4BB16277-C1B3-4732-8AF5-7B8D7E422FAD Q37742252-F4B46452-7E01-4CC7-B3D9-A29A4D03AEFB Q38553440-E9CCBCAF-0E80-4A5E-B40F-08DAB2B3BD57 Q38560299-94F48914-D730-4835-83AC-6FFEF4DD9EDC Q38610744-32C9A110-DD10-4D6A-841E-3B43DE7F40B6 Q38646284-EF427458-E832-4949-AC54-36CB148D0303 Q38653259-6D69E68D-D689-4959-9BA3-37281C4F9117 Q38683101-9957E8E0-022F-4073-AE2C-7BB651463E54 Q38711698-4FFDF36C-515A-433A-99FE-E186BA3688B5 Q38786620-1E21803D-6107-44FC-AD37-B0E342E10D27 Q38883793-6727CA14-85AE-4328-9C05-6B939CD32EF3 Q38916677-19703897-2DD4-4382-BEE9-CD54DB5E731D Q38985818-172B1EE6-A535-4A36-B7E7-B270376D564D Q39018200-FE966432-8F2C-42BF-AD23-3CC56DE7ADBA Q39175024-F4B73278-F46A-4664-98F5-360C2FC065E7 Q39235326-1B598F06-CB3A-4ED7-96B9-538135B513EA

P2860

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

http://www.wikidata.org/entity/Q34100598

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@ast

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@en

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@nl

type

label

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@ast

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@en

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@nl

prefLabel

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@ast

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@en

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@nl

P1433

Q34100598-82ECA969-08FB-4F49-9570-4D5DF52AB33C

P1476

Q34100598-9F88C1B7-6FD4-4942-8170-1C38A8F7BF62

P2093

Q34100598-48C60DAB-03EC-401F-9B5E-61EBA1DAF578

Q34100598-671EF6BE-ADF1-4E6E-AF7F-AD60D752219C

Q34100598-9F08807E-B398-4B51-99C5-A04743964260

Q34100598-BE52F6B3-7C50-4317-876D-662FE676080F

Q34100598-C8C8C97C-B29F-47AB-AC3D-1D226C51D440

P2860

Q34100598-08338868-341E-477D-8ABD-92CF8ADA6C08

Q34100598-0C2FDCC0-91E6-4285-BD01-553381675283

Q34100598-16F05C66-572B-4B80-B928-722717D26559

Q34100598-17162534-FC13-4D48-8A60-E400B1370EC3

Q34100598-19E562FF-FC3E-427D-A352-A62F6F5008E1

Q34100598-2DFD5526-BE64-4715-9B08-67289AE6BC0D

Q34100598-3BB30849-F59A-4756-8889-D60B97FD41A4

Q34100598-3F0D2336-70EE-4C89-B14A-D5F572C07352

Q34100598-46E4E375-8380-4DF3-8D3A-91F73D6211D4

Q34100598-4B1ABB3F-0635-4DE8-866C-59C9ED6E1C12

P2888

Q34100598-73E9F1B7-7E01-4133-A967-EB4DB126DA35

P304

Q34100598-5B5F4E60-BDD5-41E3-929A-4C3B4ECD1790

P31

Q34100598-14FB343A-53FF-4362-8DB5-5A123A170F2A

P356

Q34100598-DF34787C-E9FD-437F-B19D-C6D406AEF449

P433

Q34100598-B94EDD95-577F-41A3-9D4E-527672328433

P478

Q34100598-FA3F3508-9581-4823-833D-5A659D8C5848

P50

Q34100598-2CF82136-6DC7-475E-B451-C77AE6F61571

Q34100598-6093FF2B-0833-4202-987B-65CF30A394CA

Q34100598-75997F9F-D603-4977-B036-E282530F58FC

Q34100598-86D0146A-882A-4BE2-8141-F22F0329C279

Q34100598-F37F31E8-CF83-4C29-9E39-454CA9D3CFAB

P577

Q34100598-5AAA1DB3-8E60-42D2-9086-2ECECC77498E

P5875

Q34100598-9B9B9E93-0AF9-4B31-9C0A-82BFFA9A09EA

P698

Q34100598-DA8FB528-B401-4520-B803-CB28DFD3E77B

P921

Q34100598-DE787FA4-2826-44FC-9BE3-37098B9E3255

P932

Q34100598-44537974-3B69-4CF1-A31C-25B67066DADA

P356

S00134-014-3408-3

P1433

Intensive Care Medicine

P1476

Worrisome trends in incidence ...... units (Paris area, 2002-2010)

@en

P2093

Charlotte Renaudat

http://www.w3.org/2001/XMLSchema#string

Françoise Dromer

http://www.w3.org/2001/XMLSchema#string

French Mycosis Study Group

http://www.w3.org/2001/XMLSchema#string

Karine Sitbon

http://www.w3.org/2001/XMLSchema#string

Michel Wolff

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

Epidemiology of invasive candidiasis: a persistent public health problem

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.

P2888

s00134-014-3408-3

P304

1303-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-014-3408-3

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

Arnaud Fontanet

Olivier Lortholary

Stéphane Bretagne

Lise Denoeud-Ndam

P577

2014-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264639759

http://www.w3.org/2001/XMLSchema#string

P698

25097069

http://www.w3.org/2001/XMLSchema#string

P921

intensive care unit

P932

4147247

http://www.w3.org/2001/XMLSchema#string